NDA 021594 · Intl Medication Sys
Amiodarone Hydrochloride
Amiodarone Hydrochloride · Injection
DiscontinuedLast checked: Nov 20, 2026Latest source record: Feb 4, 2004 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2004
Feb 4, 2004
Approved uses
1
Original approval plus efficacy supplements
Registered trials
185
52 Phase 3, 17 recruiting
FAERS reports
9,185
7,993 serious, 1,582 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Feb 4, 2004 Original approval · Type 5 - New Formulation or New Manufacturer ReviewOther Important Information from FDALetter
1 products under this application
- AMIODARONE HYDROCHLORIDE · AMIODARONE HYDROCHLORIDE 50MG/ML · INJECTABLE, INJECTION · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Amiodarone" as an intervention, any sponsor and status, largest first.
- A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial FibrillationPivotal-lookingCompleted
SanofiSanofi (SNY)
NCT00174785 · 4,628 participants · Start Jun 2005 · Primary completion Mar 2008
Drug: dronedarone (SR33589); placebo · For: Atrial Fibrillation; Atrial Flutter
Sites: Bridgewater, New Jersey; Buenos Aires, Argentina; New South Wales, Australia · 37 sites in all
- Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard TherapyPivotal-lookingTerminated
SanofiSanofi (SNY)
NCT01151137 · 3,236 participants · Start Jul 2010 · Primary completion Sep 2011
Drug: Dronedarone; Placebo (for Dronedarone) · For: Atrial Fibrillation
Sites: Bridgewater, New Jersey; Buenos Aires, Argentina; Macquarie Park, Australia · 37 sites in all
- Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or TachycardiaPivotal-lookingCompleted
University of WashingtonAcademic, hospital or other
NCT01401647 · 3,024 participants · Start May 2012 · Primary completion Dec 2015
Drug: amiodarone; Lidocaine · For: Cardiac Arrest
Sites: Birmingham, Alabama; San Diego, California; Portland, Oregon · 9 sites in all
- Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation TrialPivotal-lookingCompleted
Mayo ClinicAcademic, hospital or other
NCT00911508 · 2,204 participants · Start Nov 13, 2009 · Primary completion Dec 31, 2017
Drug: Rate or Rhythm Control Therapy · For: Atrial Fibrillation; Arrhythmia
Sites: Little Rock, Arkansas; Los Angeles, California; Sacramento, California · 118 sites in all
- Kansai Plus Atrial Fibrillation TrialPivotal-lookingCompleted
Kyoto University, Graduate School of MedicineAcademic, hospital or other
NCT01477983 · 2,113 participants · Start Nov 2011 · Primary completion Jul 2017
Drug: Antiarrhythmic drug (AAD); Control and 2 more · For: Atrial Fibrillation
Sites: Kyoto, Japan
- Dronedarone Rhythm Intervention for Early Atrial FibrillationPivotal-lookingNot yet recruiting
Inha University HospitalAcademic, hospital or other
NCT07270848 · 1,898 participants (planned) · Start Jan 1, 2026 · Primary completion Jun 2028
Drug: Dronedarone; flecainide and 1 more · For: Atrial Fibrillation (AF)
Sites: Incheon, South Korea; Ansan, South Korea; Bucheon-si, South Korea · 16 sites in all
Wuhan UniversityAcademic, hospital or other
NCT01341353 · 1,800 participants (planned) · Start Apr 2011 · Primary completion Dec 2014
Drug: Digaoxin,amiodarone,β receptor antagonist, Calcium Antagonists · For: Atrial Fibrillation
Sites: Wuhan, China
- Amiodarone Against ICD Therapy in Chagas Cardiomyopathy for Primary Prevention of DeathPivotal-lookingStatus unknown
InCor Heart InstituteAcademic, hospital or other
NCT01722942 · 1,100 participants (planned) · Start Oct 6, 2014 · Primary completion Jul 31, 2022
Drug: amiodarone hydrochloride · For: Chagas Cardiomyopathy; Non-sustained Ventricular Tachycardia; At Least 10 Points in Rassi Risk Score for Death
Sites: Fortaleza, Brazil; Salvador, Brazil; Brasília, Brazil · 20 sites in all
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- dyspnoea997
- off label use869
- asthenia835
- fatigue770
- drug ineffective688
- product use in unapproved indication648
- nausea545
- cough528
- dizziness471
- atrial fibrillation465
- pneumonia449
- vomiting439
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 59 |
| 2005 | 106 |
| 2006 | 83 |
| 2007 | 68 |
| 2008 | 41 |
| 2009 | 108 |
| 2010 | 119 |
| 2011 | 140 |
| 2012 | 332 |
| 2013 | 144 |
| 2014 | 142 |
| 2015 | 157 |
| 2016 | 179 |
| 2017 | 492 |
| 2018 | 479 |
| 2019 | 596 |
| 2020 | 592 |
| 2021 | 833 |
| 2022 | 916 |
| 2023 | 916 |
| 2024 | 1,042 |
| 2025 | 1,033 |
| 2026 | 606 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
Ortiz M, Martín A, Arribas F, et al. · Eur Heart J 2017 · Comparative Study, Multicenter Study
- Amiodarone or Implantable Cardioverter-Defibrillator in Chagas Cardiomyopathy: The CHAGASICS Randomized Clinical Trial.
Martinelli-Filho M, Marin-Neto JA, Scanavacca MI, et al. · JAMA Cardiol 2024 · Randomized Controlled Trial, Multicenter Study
- Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Kudenchuk PJ, Brown SP, Daya M, et al. · N Engl J Med 2016 · Comparative Study, Multicenter Study
- Prevalence of amiodarone-induced hypothyroidism; A systematic review and meta-analysis.
Mohammadi K, Shafie D, Vakhshoori M, et al. · Trends Cardiovasc Med 2023 · Meta-Analysis, Systematic Review
- Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
Bardy GH, Lee KL, Mark DB, et al. · N Engl J Med 2005 · Clinical Trial, Comparative Study
- Amiodarone or lidocaine for cardiac arrest: A systematic review and meta-analysis.
Sanfilippo F, Corredor C, Santonocito C, et al. · Resuscitation 2016 · Meta-Analysis, Systematic Review
Sponsor: Intl Medication Sys
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.